TD Ameritrade Investment Management’s AbbVie ABBV Stock Holding History

TD Ameritrade Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,075	Closed	-$280K	–	3
2023 Q2	$280K	Sell	2,075 -347	-14%	-$50.9K	﹤0.01%	141
2023 Q1	$386K	Sell	2,422 -607	-20%	-$92.8K	﹤0.01%	132
2022 Q4	$490K	Sell	3,029 -2,053	-40%	-$315K	﹤0.01%	134
2022 Q3	$682K	Sell	5,082 -1,008	-17%	-$145K	0.01%	127
2022 Q2	$933K	Sell	6,090 -2,775	-31%	-$424K	0.01%	124
2022 Q1	$1.44M	Buy	8,865 +659	+8%	+$95.7K	0.01%	119
2021 Q4	$1.11M	Buy	8,206 +573	+8%	+$67.7K	0.01%	121
2021 Q3	$669K	Buy	7,633 +138	+2%	+$15.8K	0.01%	138
2021 Q2	$844K	Buy	7,495 +1,213	+19%	+$137K	0.01%	127
2021 Q1	$673K	Hold	6,282	–	–	0.01%	134
2020 Q4	$673K	Sell	6,282 -1,351	-18%	-$130K	0.01%	134
2020 Q3	$669K	Sell	7,633 -872	-10%	-$82.1K	0.01%	138
2020 Q2	$835K	Sell	8,505 -2,258	-21%	-$199K	0.01%	127
2020 Q1	$820K	Sell	10,763 -2,692	-20%	-$229K	0.01%	126
2019 Q4	$1.19M	Buy	13,455 +3,347	+33%	+$278K	0.01%	118
2019 Q3	$765K	Buy	10,108 +1,541	+18%	+$106K	0.01%	139
2019 Q2	$623K	Buy	8,567 +1,000	+13%	+$78.6K	0.01%	138
2019 Q1	$610K	Buy	7,567 +2,359	+45%	+$193K	0.01%	131
2018 Q4	$480K	Buy	5,208 +1,713	+49%	+$151K	﹤0.01%	119
2018 Q3	$331K	Buy	3,495 +2,786	+393%	+$264K	﹤0.01%	117
2018 Q2	$66K	Buy	+709	New	+$69.2K	﹤0.01%	125

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TD Ameritrade Investment Management's ABBV Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 2,075 shares — an estimated $280K sold.

TD Ameritrade Investment Management first reported a position in ABBV in Q2 2018 and held it in 21 quarters. The position peaked at $1.44M in Q1 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

TD Ameritrade Investment Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
TD Ameritrade Investment Management sold 2,075 AbbVie shares in Q3 2023, an estimated $280K.
TD Ameritrade Investment Management first reported a position in AbbVie in Q2 2018 and held it in 21 quarters.
TD Ameritrade Investment Management's AbbVie position peaked at $1.44M in Q1 2022.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.